Case Background

On August 10, 2018, Aralez Pharmaceuticals US Inc. and 6 affiliated debtors (collectively, the "Debtors") each filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Southern District of New York. The cases are pending before the Honorable Martin Glenn and are jointly administered under Case No. 18-12425.

Important Information & Dates

Plan & Disclosure Statement

On February 5, 2019, the Debtors filed their Plan of Liquidation and the Disclosure Statement related thereto. On March 8, 2019, the Bankruptcy Court entered an order approving the Disclosure Statement.  The Bankruptcy Court will hold a hearing to consider confirmation of the Plan on May 6, 2019 at 10:00 a.m. (ET).

Deadline to File Claims

The Bankruptcy Court has set the following deadlines for filing proofs of claim against the Debtors:

• General Bar Date (all creditors other than Governmental Units): November 29, 2018 at 5:00 p.m. (ET)
• Governmental Unit Bar Date: February 6, 2019 at 5:00 p.m. (ET)

Click on "Submit a Claim" above to download a proof of claim form and for more information regarding filing a claim against the Debtors.

Hearing on First Day Motions

A hearing on the Debtors' First Day Motions was held on August 13, 2018 at 11:00 a.m. (ET) before the Honorable Martin Glenn, United States Bankruptcy Court for the Southern District of New York, One Bowling Green, Courtroom 523, New York, New York 10004.  A final hearing on certain of the First Day Motions was held on September 13, 2018 at 10:00 a.m. 

Please click below to view and download the Debtors' First Day Motions and Orders:

First Day Motions

First Day Orders